Wave Life Sciences, Inc. (WVE)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch WVE
See up to 3 months of WVE. The 7-day demo opens the 1M and 3M ranges and puts WVE on your watchlist.
Start 7-day demoLatest WVE insider trades
About Wave Life Sciences, Inc. (WVE)
The SEC lists Wave Life Sciences, Inc. under CIK 0001631574, in pharmaceutical preparations. It is grouped with Health Care companies on this site.
WVE Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 4 | 23,996 | $135K |
| Grant or award | 16 | 597,600 | |
| Option exercise | 2 | 14,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
WVE insider transactions (Form 4)
12950 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. - Director | Grant or award | Common Stock | 10,700 footnote F1 | $0.00 | - | |
| RA CAPITAL MANAGEMENT, L.P. - Director | Grant or award | Stock Option (Right to Buy) | 64,000 | $0.00 | - | |
| ||||||
| Gregory L. Verdine - Director | Grant or award | Common Stock | 10,700 footnote F1 | $0.00 | - | |
| Gregory L. Verdine - Director | Grant or award | Stock Option (right to buy) | 64,000 | $0.00 | - | |
| ||||||
| Aik Na Tan - Director | Grant or award | Common Stock | 10,700 footnote F1 | $0.00 | - | |
| Aik Na Tan - Director | Grant or award | Stock Option (right to buy) | 64,000 | $0.00 | - | |
| ||||||
| Ken Takanashi - Director | Grant or award | Common Stock | 10,700 footnote F1 | $0.00 | - | |
| Ken Takanashi - Director | Grant or award | Stock Option (right to buy) | 64,000 | $0.00 | - | |
| ||||||
 Mark Corrigan - Director | Grant or award | Common Stock | 10,700 footnote F1 | $0.00 | - | |
| Mark Corrigan - Director | Grant or award | Stock Option (right to buy) | 64,000 | $0.00 | - | |
| ||||||
| Adrian Rawcliffe - Director | Grant or award | Common Stock | 10,700 footnote F1 | $0.00 | - | |
| Adrian Rawcliffe - Director | Grant or award | Stock Option (right to buy) | 64,000 | $0.00 | - | |
| ||||||
| Heidi L. Wagner - Director | Grant or award | Common Stock | 10,700 footnote F1 | $0.00 | - | |
| Heidi L. Wagner - Director | Grant or award | Stock Option (right to buy) | 64,000 | $0.00 | - | |
| ||||||
| Christian O. Henry - Director | Grant or award | Common Stock | 10,700 footnote F1 | $0.00 | - | |
| Christian O. Henry - Director | Grant or award | Stock Option (right to buy) | 64,000 | $0.00 | - | |
| ||||||
| Heidi L. Wagner - Director | Option exercise | Common Stock | 7,000 | $5.97 | $42K | |
| Heidi L. Wagner - Director | Open-market sale | Common Stock | 7,000 | $6.01 | $42K | |
| Heidi L. Wagner - Director | Option exercise | Stock Option (right to buy) | 7,000 | $0.00 | - | |
| Adrian Rawcliffe - Director | Open-market sale | Common Stock | 12,700 | $5.29 footnote F2 | $67K | |
| ||||||
| Ken Takanashi - Director | Open-market sale | Common Stock | 3,864 footnote F1 | $6.01 footnote F2 | $23K | |
| ||||||
| Aik Na Tan - Director | Open-market sale | Common Stock | 432 | $6.01 | $3K | |
| RA CAPITAL MANAGEMENT, L.P. | Open-market purchase | Ordinary Shares | 4,954,558 | $6.06 footnote F1 | $30.02M | |
| RA CAPITAL MANAGEMENT, L.P. | Open-market purchase | Ordinary Shares | 351,224 | $6.38 footnote F4 | $2.24M | |
| RA CAPITAL MANAGEMENT, L.P. | Open-market purchase | Ordinary Shares | 2,495,623 | $6.43 footnote F5 | $16.05M | |
| RA CAPITAL MANAGEMENT, L.P. | Open-market purchase | Ordinary Shares | 971,091 | $6.50 footnote F6 | $6.31M | |
| ||||||
| Ken Takanashi | Other | Ordinary Shares | 3,901,348 footnote F2 | $0.00 | - | |
| Ken Takanashi | Other | Series A Preferred Shares | 3,901,348 footnote F2 | $0.00 | - | |
| ||||||
| Chris Francis - Officer | Option exercise | Ordinary Shares | 17,900 | $3.87 | $69K | |
| Chris Francis - Officer | Open-market sale | Ordinary Shares | 17,900 | $15.09 footnote F4 | $270K | |
| Chris Francis - Officer | Option exercise | Ordinary Shares | 15,294 | $4.75 | $73K | |
| Chris Francis - Officer | Open-market sale | Ordinary Shares | 15,294 | $15.00 | $229K | |
| Chris Francis - Officer | Option exercise | Share Option (right to buy) | 17,900 | $0.00 | - | |
| Chris Francis - Officer | Option exercise | Share Option (right to buy) | 15,294 | $0.00 | - | |
| ||||||
| Kyle Moran - Officer | Grant or award | Ordinary Shares | 45,625 footnote F1 | $0.00 | - | |
| Kyle Moran - Officer | Open-market sale | Ordinary Shares | 3,588 | $13.45 | $48K | |
| Kyle Moran - Officer | Grant or award | Share Option (right to buy) | 273,750 | $0.00 | - | |
| ||||||
| Paul Bolno - Officer | Grant or award | Ordinary Shares | 165,000 footnote F1 | $0.00 | - | |
| Paul Bolno - Officer | Open-market sale | Ordinary Shares | 10,480 | $13.45 | $141K | |
| Paul Bolno - Officer | Grant or award | Share Option (right to buy) | 1,000,000 | $0.00 | - | |
| ||||||
| Chris Francis - Officer | Grant or award | Ordinary Shares | 38,750 footnote F1 | $0.00 | - | |
| Chris Francis - Officer | Open-market sale | Ordinary Shares | 1,883 | $13.45 | $25K | |
| Chris Francis - Officer | Grant or award | Share Option (right to buy) | 232,500 | $0.00 | - | |
| ||||||
| Chandra Vargeese - Officer | Grant or award | Ordinary Shares | 45,625 footnote F1 | $0.00 | - | |
| Chandra Vargeese - Officer | Open-market sale | Ordinary Shares | 3,228 | $13.45 | $43K | |
| Chandra Vargeese - Officer | Grant or award | Share Option (right to buy) | 273,750 | $0.00 | - | |
| ||||||
| Chris Francis - Officer | Option exercise | Ordinary Shares | 9,375 | $3.14 | $29K | |
| Chris Francis - Officer | Open-market sale | Ordinary Shares | 8,080 | $15.92 | $129K | |
| Chris Francis - Officer | Open-market sale | Ordinary Shares | 1,295 | $16.70 | $22K | |
| Chris Francis - Officer | Option exercise | Share Option (right to buy) | 9,375 | $0.00 | - | |
| Adrian Rawcliffe | Option exercise | Ordinary Shares | 42,000 | $5.97 | $251K | |
| Adrian Rawcliffe | Open-market sale | Ordinary Shares | 42,000 | $15.00 | $630K | |
| Adrian Rawcliffe | Option exercise | Share Option (right to buy) | 42,000 | $0.00 | - | |
| Heidi L. Wagner | Option exercise | Ordinary Shares | 7,000 | $5.97 | $42K | |
| Heidi L. Wagner | Option exercise | Ordinary Shares | 7,000 | $5.97 | $42K | |
| Heidi L. Wagner | Open-market sale | Ordinary Shares | 7,000 | $13.00 | $91K | |
| Heidi L. Wagner | Option exercise | Share Option (right to buy) | 14,000 | $0.00 | - | |
| Heidi L. Wagner | Open-market sale | Ordinary Shares | 7,000 | $14.00 | $98K | |
| Christian O. Henry | Open-market sale | Ordinary Shares | 6,445 | $12.75 | $82K | |
| Christian O. Henry | Option exercise | Ordinary Shares | 42,000 | $5.97 | $251K | |
| Christian O. Henry | Open-market sale | Ordinary Shares | 42,000 | $12.75 | $536K | |
| Christian O. Henry | Option exercise | Ordinary Shares | 15,000 | $3.50 | $53K | |
| Christian O. Henry | Open-market sale | Ordinary Shares | 15,000 | $14.07 footnote F3 | $211K | |
| Christian O. Henry | Option exercise | Ordinary Shares | 30,000 | $4.59 | $138K | |
| Christian O. Henry | Open-market sale | Ordinary Shares | 30,000 | $18.02 footnote F4 | $541K | |
| Christian O. Henry | Option exercise | Share Option (right to buy) | 42,000 | $0.00 | - | |
| Christian O. Henry | Option exercise | Share Option (right to buy) | 15,000 | $0.00 | - | |
| Christian O. Henry | Option exercise | Share Option (right to buy) | 30,000 | $0.00 | - | |
| ||||||
| Aik Na Tan | Open-market sale | Ordinary Shares | 7,494 | $12.75 | $96K | |
| Aik Na Tan | Open-market sale | Ordinary Shares | 7,494 | $15.00 | $112K | |
| Aik Na Tan | Option exercise | Share Option (right to buy) | 21,000 | $0.00 | - | |
| Aik Na Tan | Option exercise | Ordinary Shares | 32,230 | $5.37 | $173K | |
| Aik Na Tan | Open-market sale | Ordinary Shares | 15,000 | $12.75 | $191K | |
| Aik Na Tan | Open-market sale | Ordinary Shares | 17,230 | $15.00 | $258K | |
| Aik Na Tan | Option exercise | Ordinary Shares | 45,000 | $4.59 | $206K | |
| Aik Na Tan | Open-market sale | Ordinary Shares | 20,000 | $12.75 | $255K | |
| Aik Na Tan | Open-market sale | Ordinary Shares | 25,000 | $15.00 | $375K | |
| Aik Na Tan | Option exercise | Ordinary Shares | 21,000 | $3.50 | $74K | |
| Aik Na Tan | Open-market sale | Ordinary Shares | 21,000 | $12.75 | $268K | |
| Aik Na Tan | Open-market sale | Ordinary Shares | 21,000 | $12.75 | $268K | |
| Aik Na Tan | Option exercise | Ordinary Shares | 21,000 | $5.97 | $125K | |
| Aik Na Tan | Option exercise | Share Option (right to buy) | 32,230 | $0.00 | - | |
| Aik Na Tan | Option exercise | Share Option (right to buy) | 45,000 | $0.00 | - | |
| Aik Na Tan | Option exercise | Share Option (right to buy) | 21,000 | $0.00 | - | |
| Gregory L. Verdine | Open-market sale | Ordinary Shares | 12,020 | $13.09 footnote F2 | $157K | |
| Gregory L. Verdine | Open-market sale | Ordinary Shares | 7,980 | $14.05 footnote F3 | $112K | |
| ||||||
| Chris Francis - Officer | Option exercise | Ordinary Shares | 28,125 | $3.14 | $88K | |
| Chris Francis - Officer | Open-market sale | Ordinary Shares | 28,125 | $14.50 | $408K | |
| Chris Francis - Officer | Option exercise | Ordinary Shares | 107,400 | $3.87 | $416K | |
| Chris Francis - Officer | Option exercise | Ordinary Shares | 22,500 | $2.83 | $64K | |
| Chris Francis - Officer | Open-market sale | Ordinary Shares | 107,400 | $14.56 footnote F4 | $1.56M | |
| Chris Francis - Officer | Option exercise | Ordinary Shares | 45,882 | $4.75 | $218K | |
| Chris Francis - Officer | Open-market sale | Ordinary Shares | 45,882 | $14.50 | $665K | |
| Chris Francis - Officer | Option exercise | Ordinary Shares | 9,375 | $3.14 | $29K | |
| Chris Francis - Officer | Open-market sale | Ordinary Shares | 9,375 | $15.00 | $141K | |
| Chris Francis - Officer | Option exercise | Ordinary Shares | 37,500 | $3.14 | $118K | |
| Chris Francis - Officer | Open-market sale | Ordinary Shares | 37,500 | $14.08 | $528K | |
| Chris Francis - Officer | Option exercise | Ordinary Shares | 17,900 | $3.87 | $69K | |
| Chris Francis - Officer | Open-market sale | Ordinary Shares | 17,900 | $15.00 | $269K | |
| Chris Francis - Officer | Option exercise | Ordinary Shares | 122,349 | $4.75 | $581K | |
| Chris Francis - Officer | Open-market sale | Ordinary Shares | 122,349 | $14.20 footnote F6 | $1.74M | |
| Chris Francis - Officer | Option exercise | Ordinary Shares | 50,000 | $10.48 | $524K | |
| Chris Francis - Officer | Open-market sale | Ordinary Shares | 50,000 | $16.00 | $800K | |
| Chris Francis - Officer | Open-market sale | Ordinary Shares | 22,500 | $14.08 | $317K | |
| Chris Francis - Officer | Option exercise | Share Option (right to buy) | 75,000 | $0.00 | - | |
| Chris Francis - Officer | Option exercise | Share Option (right to buy) | 125,300 | $0.00 | - | |
| Chris Francis - Officer | Option exercise | Share Option (right to buy) | 168,231 | $0.00 | - | |
| Chris Francis - Officer | Option exercise | Share Option (right to buy) | 50,000 | $0.00 | - | |
| Chris Francis - Officer | Option exercise | Share Option (right to buy) | 22,500 | $0.00 | - | |
| ||||||
| Kyle Moran - Officer | Option exercise | Ordinary Shares | 60,000 | $2.83 | $170K | |
| Kyle Moran - Officer | Open-market sale | Ordinary Shares | 60,000 | $13.20 | $792K | |
| Kyle Moran - Officer | Option exercise | Ordinary Shares | 100,000 | $3.14 | $314K | |
| Kyle Moran - Officer | Open-market sale | Ordinary Shares | 50,000 | $15.00 footnote F4 | $750K | |
| Kyle Moran - Officer | Open-market sale | Ordinary Shares | 50,000 | $13.20 | $660K | |
| Kyle Moran - Officer | Option exercise | Ordinary Shares | 50,000 | $4.75 | $238K | |
| Kyle Moran - Officer | Open-market sale | Ordinary Shares | 50,000 | $18.00 | $900K | |
| Kyle Moran - Officer | Option exercise | Ordinary Shares | 36,000 | $8.17 | $294K | |
| Kyle Moran - Officer | Open-market sale | Ordinary Shares | 36 | $20.25 footnote F6 | $729 | |
| Kyle Moran - Officer | Option exercise | Ordinary Shares | 50,000 | $10.48 | $524K | |
| Kyle Moran - Officer | Open-market sale | Ordinary Shares | 50,000 | $20.03 footnote F6 | $1.00M | |
| Kyle Moran - Officer | Grant or award | Share Option (right to buy) | 60,000 | $0.00 | - | |
| Kyle Moran - Officer | Grant or award | Share Option (right to buy) | 100,000 | $0.00 | - | |
| Kyle Moran - Officer | Grant or award | Share Option (right to buy) | 50,000 | $0.00 | - | |
| Kyle Moran - Officer | Grant or award | Share Option (right to buy) | 36,000 | $0.00 | - | |
| Kyle Moran - Officer | Grant or award | Share Option (right to buy) | 50,000 | $0.00 | - | |
| ||||||
| Mark Corrigan | Open-market sale | Ordinary Shares | 9,600 footnote F1 | $13.09 footnote F2 | $126K | |
| Mark Corrigan | Open-market sale | Ordinary Shares | 6,515 footnote F1 | $14.07 footnote F3 | $92K | |
| ||||||
| Adrian Rawcliffe | Open-market sale | Ordinary Shares | 16,115 | $6.79 footnote F2 | $109K | |
| ||||||
| RA CAPITAL MANAGEMENT, L.P. | Open-market purchase | Ordinary Shares | 1,000 footnote F1 | $6.69 footnote F2 | $7K | |
| ||||||
Item 1.01, 3.02, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01
Item 2.02, 7.01, 9.01
Item 5.07
Item 7.01, 8.01, 9.01
Recent WVE Form 144 notices of proposed sale
2An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| ADRIAN G RAWCLIFFE | Director | 12,700 | $64K | View on EDGAR | |
| HEIDI L WAGNER | Director | 7,000 | $42K |
WVE insider trading FAQ
What is the latest insider trade for WVE?
Wave Life Sciences, Inc. (WVE) had 12 insider filings in the last 90 days, with the most recent on 2026-10-08. The full record for WVE runs to 50 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying WVE stock?
No insider purchases of WVE were filed in the last 90 days. 6 purchases are on record for this company.
How many insiders are selling WVE stock?
4 insider sales of WVE were filed in the last 90 days, totaling $135K.
Where can I see WVE SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects WVE Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - RA CAPITAL MANAGEMENT, L.P. view on EDGAR
- - Gregory L. Verdine view on EDGAR
- - Aik Na Tan view on EDGAR
- - Ken Takanashi view on EDGAR
- - Mark Corrigan view on EDGAR
- - Adrian Rawcliffe view on EDGAR
- - Heidi L. Wagner view on EDGAR
- - Christian O. Henry view on EDGAR
- - Heidi L. Wagner view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where WVE's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow WVE with a 7-day demo
- WVE on your watchlist
- Every WVE Form 4 filing on record
- Up to 3 months of WVE price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
